This page shows the latest kidney disease news and features for those working in and with pharma, biotech and healthcare.
Fabry disease is a rare disorder in which patients inherit a deficiency of the α–Galactosidase–A enzyme. ... Fabry disease is a rare inherited disorder. Patients inherit a deficiency of the α–Galactosidase–A enzyme that results in the breakdown
Bayer has scored a US Food and Drug Administration (FDA) priority review for its investigational drug finerenone for patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). ... Overactivation of the mineralocorticoid receptor is believed to
AstraZeneca (AZ) has revealed some impressive results from a phase 3 study of its heart failure drug Farxiga in chronic kidney disease (CKD) at the European Society of Cardiology (ESC) virtual ... It is often caused by diabetes, hypertension and
The drug is also being evaluated in a phase 2 clinical trial in type 1 diabetes and kidney disease, and a further phase 2 trial of the drug in IPF is ... Genkyotex’s platform identifies small molecules which can selectively inhibit specific NOX enzymes
Earlier this week, AZ also touted results for Farxiga in kidney disease, after the drug reduced kidney disease progression in a phase 3 trial of patients with chronic kidney disease ... In March, the US Food and Drug Administration (FDA) gave Jardiance
It also signed a $2.35bn deal with Nurix for protein degradation drugs for cancer and other diseases, and a $2bn alliance with Goldfinch Bio in the kidney disease area, continuing
More from news
Approximately 22 fully matching, plus 142 partially matching documents found.
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care. ... AstraZeneca's R&D centre in Cambridge, UK. Moderate to severe chronic kidney disease (CKD) is an under-recognised public health
4. Vadadustat is an inhibitor of hypoxiainducible factor (HIF)-prolyl hydroxylase (HIF-PH) from Akebia Therapeutics/ Mitsubishi Tanabe Pharma/Otsuka that targets anaemia in chronic kidney disease (CKD). ... Hypercholesterolemia is a major risk of
If we don’t drink enough water, it can lead to headaches, constipation, tiredness and more serious problems, such as urinary infections and kidney disease. ... This could be a side effect of a condition such as stroke, motor neurone disease, multiple
The firm has just signed a long-term collaboration with AZ for the discovery of new drugs for chronic kidney disease and idiopathic pulmonary fibrosis (IPF). ... disease and applying machine learning, artificial intelligence and collapsing analysis to
of JAK proteins is an established method of controlling the symptoms of this disease. ... The sales forecast for Zolgensma is $2.09bn. Roxadustat, from AstraZeneca, FibroGen and Astellas, targets anaemia in chronic kidney disease (CKD).
More from intelligence
Approximately 1 fully matching, plus 20 partially matching documents found.
Alex arrives here with first class operational and clinical development expertise in novel drug therapies, targeting cardiovascular and metabolic disease and kidney disease amongst others.
of iron deficiency anaemia in adult patients with chronic kidney disease.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
However, once these trials are divided up into specific diseases the underrepresentation becomes clearer, especially in the fields of cardiovascular diseases, hepatitis, HIV, chronic kidney disease and digestive diseases.
Mircera, used in the treatment of anaemia in Chronic Kidney Disease (CKD), was approved in 2007 by the European Medicines Agency (EMA) for once-monthly dosing as opposed to weekly dosing ... Ensuring market access for biobetters. Biobetters provide
Our client’s main objectives were to:. Establish an independent review committee comprising experienced nephrologists and academics specializing in research related to kidney disease.
In 2018 there were 220 million more heatwave exposures affecting older populations increasing risks of heart and kidney stress and disease and stroke.
One in 4 adults in the UK has high blood pressure so the risk of developing heart disease, heart attacks, strokes, kidney disease and vascular dementia are very real. ... Lack of exercise. Being overweight. Chronic Kidney Disease. Regularly drinking
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
MadMicrobe is an award-winning team of certified medical illustrators creating animations that draw audiences into a world of suspense, excitement,...